Intranasal CRMP2-Ubc9 inhibitor regulates NaV1.7 to alleviate trigeminal neuropathic pain. Loya-Lopez SI, Allen HN, Duran P, Calderon-Rivera A, et al. Pain 2023 Sep 26. doi: 10.1097/j.pain.0000000000003053.

Read + Share

Amedeo Smart

Independent Medical Education

Loya-Lopez SI, Allen HN, Duran P, Calderon-Rivera A, et al. Intranasal CRMP2-Ubc9 inhibitor regulates NaV1.7 to alleviate trigeminal neuropathic pain. Pain 2023 Sep 26. doi: 10.1097/j.pain.0000000000003053.
PMID: 37751532